Literature DB >> 19785921

Bidirectional signaling of ErbB and Eph receptors at synapses.

Yu Chen1, Amy K Y Fu, Nancy Y Ip.   

Abstract

Synapse development and remodeling are regulated by a plethora of molecules such as receptor tyrosine kinases (RTKs), a family of cell surface receptors that play critical roles in neural development. Two families of RTKs implicated in synaptic functions, ErbBs and Ephs, share similar characteristics in terms of exhibiting forward and reverse signaling. In this review, we will discuss the latest advances in the functions of ErbBs and Ephs at the synapse, including dendritic spine morphogenesis, synapse formation and maturation, and synaptic transmission and plasticity. In addition to signaling at interneuronal synapses, communication between neuron and glia is increasingly implicated in the control of synaptic functions. Studies on RTKs and their cognate ligands in glial cells enhance our understanding on the nature of 'tripartite synapse'. Implications of these signaling events in human diseases will be discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19785921     DOI: 10.1017/S1740925X09990287

Source DB:  PubMed          Journal:  Neuron Glia Biol        ISSN: 1740-925X


  16 in total

Review 1.  Getting neural circuits into shape with semaphorins.

Authors:  R Jeroen Pasterkamp
Journal:  Nat Rev Neurosci       Date:  2012-08-16       Impact factor: 34.870

2.  Blockade of EphA4 signaling ameliorates hippocampal synaptic dysfunctions in mouse models of Alzheimer's disease.

Authors:  Amy K Y Fu; Kwok-Wang Hung; Huiqian Huang; Shuo Gu; Yang Shen; Elaine Y L Cheng; Fanny C F Ip; Xuhui Huang; Wing-Yu Fu; Nancy Y Ip
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-23       Impact factor: 11.205

3.  A Cell-Surface Membrane Protein Signature for Glioblastoma.

Authors:  Dhimankrishna Ghosh; Cory C Funk; Juan Caballero; Nameeta Shah; Katherine Rouleau; John C Earls; Liliana Soroceanu; Greg Foltz; Charles S Cobbs; Nathan D Price; Leroy Hood
Journal:  Cell Syst       Date:  2017-03-29       Impact factor: 10.304

4.  Reversing EphB2 depletion rescues cognitive functions in Alzheimer model.

Authors:  Moustapha Cissé; Brian Halabisky; Julie Harris; Nino Devidze; Dena B Dubal; Binggui Sun; Anna Orr; Gregor Lotz; Daniel H Kim; Patricia Hamto; Kaitlyn Ho; Gui-Qiu Yu; Lennart Mucke
Journal:  Nature       Date:  2010-11-28       Impact factor: 49.962

5.  Expression and activation of ephexin is altered after spinal cord injury.

Authors:  Odrick R Rosas; Johnny D Figueroa; Aranza I Torrado; Mónica Rivera; José M Santiago; Franchesca Konig-Toro; Jorge D Miranda
Journal:  Dev Neurobiol       Date:  2011-07       Impact factor: 3.964

6.  A novel method for the simultaneous enrichment, identification, and quantification of phosphopeptides and sialylated glycopeptides applied to a temporal profile of mouse brain development.

Authors:  Giuseppe Palmisano; Benjamin L Parker; Kasper Engholm-Keller; Sara Eun Lendal; Katarzyna Kulej; Melanie Schulz; Veit Schwämmle; Mark E Graham; Henrik Saxtorph; Stuart J Cordwell; Martin R Larsen
Journal:  Mol Cell Proteomics       Date:  2012-07-26       Impact factor: 5.911

7.  Eph receptors and ephrin ligands: important players in angiogenesis and tumor angiogenesis.

Authors:  Birgit Mosch; Bettina Reissenweber; Christin Neuber; Jens Pietzsch
Journal:  J Oncol       Date:  2010-03-10       Impact factor: 4.375

8.  Alzheimer's disease: synapses gone cold.

Authors:  Robert M Koffie; Bradley T Hyman; Tara L Spires-Jones
Journal:  Mol Neurodegener       Date:  2011-08-26       Impact factor: 14.195

9.  Neuregulins 1, 2, and 3 Promote Early Neurite Outgrowth in ErbB4-Expressing Cortical GABAergic Interneurons.

Authors:  Afrida Rahman-Enyart; Cary Lai; Anne L Prieto
Journal:  Mol Neurobiol       Date:  2020-06-16       Impact factor: 5.682

10.  Effects of adult exposure to bisphenol a on genes involved in the physiopathology of rat prefrontal cortex.

Authors:  Beatriz Castro; Pilar Sánchez; Jesús M Torres; Esperanza Ortega
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.